P&G Promotes Clearblue Advanced Digital To Keep Ovulation Test Lead
This article was originally published in The Tan Sheet
P&G launches a promotional campaign for the first digital test that can indicate a woman’s peak four days of ovulation under the Clearblue brand, which it markets for manufacturer SPD Swiss Precision Diagnostics.
You may also be interested in...
Perrigo predictor: Private label firm unveils its Easy Ovulation Predictor, equivalent to Inverness Medical Innovations' Clearblue Easy, at the Private Label Manufacturers Association trade show Nov. 16-18 in Chicago. The seven-test kit will ship in January. Perrigo also launched adult low-strength aspirin, a national brand equivalent (NBE) to McNeil Consumer & Specialty Pharmaceutical's St. Joseph's. The 81 mg coated tablets come in a 180-count bottle. Separately, the Allegan, Mich.-based firm received approval this month for a product comparable to Aleve Cold & Sinus...
Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.
The “Contract Manufacturing Arrangements for Drugs: Quality Agreements” draft guidance describes how parties involved in contract manufacturing of drugs can employ quality agreements to delineate their responsibilities and ensure drug quality, safety and efficacy.